SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-029377
Filing Date
2024-02-29
Accepted
2024-02-29 16:15:19
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2021 GP, L.L.C.GV 2021 GP, L.P.GV 2021, L.P.GV 2023 GP, L.L.C.GV 2023 GP, L.P.GV 2023, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm247336d1_sc13ga.htm SC 13G/A 219769
2 EXHIBIT 99.1 tm247336d1_ex99-1.htm EX-99.1 11461
  Complete submission text file 0001104659-24-029377.txt   233113
Mailing Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2019, L.P. (Filed by) CIK: 0001845041 (see all company filings)

IRS No.: 384092634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Subject) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93800 | Film No.: 24703837
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)